Laman UtamaPSTV • NASDAQ
add
Plus Therapeutics Inc
$0.25
Selepas Waktu Dagangan:(0.88%)+0.0022
$0.25
Tutup: 17 Mac, 7:32:26 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$0.26
Julat hari
$0.25 - $0.26
Julat tahun
$0.16 - $2.08
Permodalan pasaran
43.00J USD
Bilangan Purata
5.60J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Simply Wall Street
24 minit lalu
BingEx (FLX) Q3 EPS Turnaround Tests Bullish Profitability Narratives
0.72%
20.76%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.37J | -3.19% |
Perbelanjaan pengendalian | 4.17J | 33.33% |
Pendapatan bersih | -5.71J | -46.37% |
Margin untung bersih | -417.92 | -51.19% |
Pendapatan bagi setiap syer | 0.00 | 100.00% |
EBITDA | -5.60J | -57.57% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 8.61J | 138.82% |
Jumlah aset | 16.32J | 146.12% |
Jumlah liabiliti | 12.33J | -20.88% |
Jumlah ekuiti | 4.00J | — |
Syer tertunggak | 171.55J | — |
Harga kepada buku | 8.69 | — |
Pulangan pada aset | -82.04% | — |
Pulangan pada modal | -176.22% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -5.71J | -46.37% |
Tunai daripada operasi | -6.26J | -416.68% |
Tunai daripada pelaburan | -1.08J | -1,782.81% |
Tunai daripada pembiayaan | 2.80J | — |
Perubahan bersih dalam tunai | -4.53J | -295.03% |
Aliran tunai bebas | -4.01J | -1,221.55% |
Perihal
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®. Wikipedia
Diasaskan
1996
Ibu pejabat
Tapak web
Pekerja
21
